Saturday, October 7, 2017
AngioDynamics to Report Fiscal 2018 First Quarter Financial Results
ALBANY, N.Y. , Sept. 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2018 first...

  Saturday, October 7, 2017
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
ALBANY, N.Y. , Sept. 13, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C....

  Monday, September 11, 2017
AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference
ALBANY, N.Y. , Aug. 29, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer and...

  Monday, September 11, 2017
AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
ALBANY, N.Y. , Aug. 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael Greiner , Executive Vice President and Chief...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
Company posts record full-year adjusted EPS and Free Cash Flow and issues FY2018 Financial Guidance Q4 net sales of $86.9 million , down 7% year-over-year Q4 GAAP loss per share of $0.30 ; adjusted EPS of $0.19 Full Year net sales of $349.6 million , down 1% year-over-year Full Year GAAP earnings...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results
ALBANY, N.Y. , July 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 fourth...

  Monday, September 11, 2017
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
ALBANY, N.Y. , June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced the U.S. Food and Drug Administration (FDA) has granted 510(k)...

  Monday, September 11, 2017
AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access
ALBANY, N.Y. , May 31, 2017 (GLOBE NEWSWIRE) -- C.R. Bard has illegally tied the sale of its tip location systems to its line of peripherally inserted central catheters ("PICCs"), violating federal antitrust laws, preventing competition in the marketplace and limiting patient access to superior...

  Monday, September 11, 2017
AngioDynamics to Present at the 2017 UBS Global Healthcare Conference
ALBANY, N.Y. , May 09, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Michael C. Greiner , Executive Vice President and Chief...

  Monday, September 11, 2017
AngioDynamics to Present at the 41st Annual Deutsche Bank Health Care Conference
ALBANY, N.Y. , April 20, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
ALBANY, N.Y. , April 06, 2017 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the pricing of the previously announced...

  Monday, September 11, 2017
AngioDynamics Announces Secondary Offering of 2.35 Million Shares of Common Stock by Selling Stockholders
ALBANY, N.Y. , April 06, 2017 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2017 Third Quarter Results
Q3 net sales of $85.6 million , down 2% year-over-year Q3 GAAP earnings per share of $0.08 ; non-GAAP adjusted EPS up 27% from Q3 fiscal 2016 Q3 operating cash generation of $14.4 million ; free cash flow generation of $14.0 million Revised FY2017 revenue and adjusted EPS guidance; free cash flow...

  Monday, September 11, 2017
AngioDynamics To Host Investor Day on Thursday, April 6, 2017, in New York City
ALBANY, N.Y. , March 27, 2017 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will host an Investor Day on April 6, 2017 in New York City , beginning at...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2017 Third Quarter Financial Results
ALBANY, N.Y. , March 20, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 third...